From Dr. Charmaine Gittleson - Shareholder Letter (06-06-2023)
"...we engaged Dr Anthony Filippis to develop new, and strengthen existing, relationships with potential partners and to facilitate their improved understanding of the clinical and financial value of ATL1102. I appreciate that shareholders are keen to know where we are at as Anthony’s interactions are confidential and not within the public domain. I assure you he is very active in the space and is making headway in terms of inbound interest. However, this work and achieving positive results takes time and extensive diligence, and once we are in a position to do so, we will communicate with the market. "
It is your choice to believe or not to believe what she said.
New financial year, new beginning, NEW HOPE
PER Price at posting:
8.4¢ Sentiment: Buy Disclosure: Held
